Canada· CA-DIN-00886858
EMLA CREAM
A prilocain, kombinationen product containing prilocaine + lidocaine, registered in Canada by ASPEN PHARMACARE CANADA INC.. The same ATC class is registered in 7 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Prilocain, kombinationen is registered in 7 of 19 countries.
Countries holding a registration under ATC N01BB54 (prilocain, kombinationen), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 3 of them publish a price we can compare per daily dose
Prilocain, kombinationen · ATC N01BB54
7 / 19 countries
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- PRILOCAINE + LIDOCAINE
- Manufacturer
- ASPEN PHARMACARE CANADA INC.
- Country
- Canada (CA)
- ATC code
- N01BB54
- ATC class
- Prilocain, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Prilocain, kombinationen in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandAnesdermPierre Fabre Medicament
- United StatesCadira Compliant Blood StatAsclemed USA, Inc.
- United KingdomDenela 5% creamTeva UK Ltd
- SwitzerlandAnesderm
- FranceANESDERM 5 %, crèmePIERRE FABRE MEDICAMENT
- CzechiaEMLAAspen Pharma Trading Limited, Dublin
- FinlandEmlaParanova Oy
- SwedenEMLA 25 mg/25 mg Medicinskt plåsterAspen Pharma Trading Limited
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Emla, Emla Pflaster
- Belgium · Emla, Emla Patch
- Cyprus · Emla, Xylocream
- Czechia · Emla
- Germany · Anesderm, Emla
- Denmark · Emla, Lidocain/Prilocain Idd
- Estonia · Nulbia
- Spain · Anamap®, Anestderma
- Finland · Emla, Oraqix
- France · Anesderm, Emla
- United Kingdom (Northern Ireland) · Emla, Nulbia
- Greece · Emla, Nulbia
- Hungary · Li-Pri
- Ireland · Emla, Oraqix
- Iceland · Emla, Fortacin
- Italy · Emla, Lidocaina E Prilocaina Teva
- Liechtenstein · Fortacin
- Luxembourg · Emla, Emla Patch
- Malta · Emla, Opralix
- Netherlands · Emla, Lidocaïne/Prilocaïne Teva
- Norway · Emla, Fortacin
- Poland · Anesderm, Emla
- Portugal · Emla, Emla Penso
- Romania · Romla
- Sweden · Emla, Oraqix
- Slovakia · Romla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7ac0bd5f-8515-4edf-9a33-b7cde4c79a2a GET /v1/drugs/7ac0bd5f-8515-4edf-9a33-b7cde4c79a2a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "00886858",
"form": "CREAM",
"class": "Human",
"routes": [
"TOPICAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N01BB54",
"schedule": [
"Ethical"
],
"drug_code": "11440",
"strengths": [
"2.5 %"
],
"ahfs_class": null,
"substances": [
"PRILOCAINE",
"LIDOCAINE"
],
"product_categorization": null
}See everything about prilocain, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.